Market Place
Sourcing Support
AbbVie Selects RIME as Quebec Recipient via adMare BioInnovations
30 Apr 2026 //
FIRSTWORD PHARMA
AbbVie Seeks FDA Approval for RINVOQ in Severe Alopecia Areata
29 Apr 2026 //
PRESS RELEASE
Kestrel Therapeutics Launches Phase 1 KST-6051 Trial
28 Apr 2026 //
GLOBENEWSWIRE
EvolveImmune Hits Preclinical Milestone with AbbVie
28 Apr 2026 //
GLOBENEWSWIRE
Abbvie Acquires KRAS Target With Option To Purchase Kestrel
28 Apr 2026 //
BIOSPACE
Abbvie Seeks FDA Approval For SKYRIZI Subcutaneous Induction
27 Apr 2026 //
PRESS RELEASE
AbbVie Provides Update on TrenibotE BLA in the US
24 Apr 2026 //
PRESS RELEASE
AbbVie to build $1.4B manufacturing campus in North Carolina
23 Apr 2026 //
PRESS RELEASE
Forge Genetics Licenses Forge Editing For Pharma Applications
14 Apr 2026 //
PHARMIWEB
Haisco Inks Exclusive Pain Medicine License Deal With Abbvie
13 Apr 2026 //
PR NEWSWIRE
AbbVie to Showcase Phase 2 ELAHERE PSOC Data at SGO 2026
12 Apr 2026 //
PR NEWSWIRE
Anthropic Puts $400M Into Coefficient Bio Life Sciences
06 Apr 2026 //
BIOSPACE
Alloy Enters Into Agreement to Advance Novel Antibody Platform
17 Mar 2026 //
BUSSINESSWIRE
AbbVie Reports Positive Ph1 Results For ABBV-295 Amylin Analog
10 Mar 2026 //
PRESS RELEASE
Abbvie Reports Phase 3 Success For SKYRIZI In Crohn`s Disease
02 Mar 2026 //
PR NEWSWIRE
FDA Approves Venclexta, Acalabrutinib For Untreated CLL Leukemia
23 Feb 2026 //
PRESS RELEASE
Abbvie Seeks FDA & EMA Approval For Upadacitinib
04 Feb 2026 //
PRESS RELEASE
Abbvie Unveils Topline Results for Epcoritamab Phase 3 Results
17 Jan 2026 //
PR NEWSWIRE
Genmab Unveils Epcoritamab Phase 3 Results
16 Jan 2026 //
PHARMIWEB
AbbVie Pens $5.6B Pact with RemeGen to join PD-1xVEGF race
12 Jan 2026 //
PRESS RELEASE
Abbvie Counters Amgen, Invests $100M In Trispecific Lung Cancer
05 Jan 2026 //
BIOSPACE
Zelgen, AbbVie Sign Up-to-$1.2B DLL3 T Cell Engager Deal
04 Jan 2026 //
FIRSTWORDPHARMA
Abbvie, Gilead Gift Themselves Clinical-Stage Cancer Drugs
02 Jan 2026 //
FIERCE BIOTECH
Redhill Bio Opaganib Shows Promise In Venetoclax-Resistant Cells
15 Dec 2025 //
PR NEWSWIRE
OSE Immuno Announces Strategic Amendment to AbbVie
09 Dec 2025 //
GLOBENEWSWIRE
Abbvie Revs Up Skyrizi Spending To Top TV Ad Totals In November
05 Dec 2025 //
FIERCE PHARMA
Abbvie To Present Latest Advances In Blood Cancer Treatments
02 Dec 2025 //
PR NEWSWIRE
Abbvie Concludes Loi With Pan-Canadian Pharma Alliance
28 Nov 2025 //
GLOBENEWSWIRE
Abbvie, Admare Bioinnovations Launch Abbvie Biotech Innovators
26 Nov 2025 //
GLOBENEWSWIRE
Biomed X Launches Neuroscience Research Partnership In US
25 Nov 2025 //
PHARMIWEB
Abbvie, Admare Bioinnovations Launch Abbvie Biotech Innovators
25 Nov 2025 //
GLOBENEWSWIRE
AbbVie Announces US FDA Approval of Epkinly
19 Nov 2025 //
PRESS RELEASE
Abbvie Reports Upadacitinib Success In Vitiligo Ph3 Trials
29 Oct 2025 //
PRESS RELEASE
Abbvie Halts Development Of Dragonfly Cancer Asset In Midflight
29 Oct 2025 //
FIERCE BIOTECH
Zag Bio Emerges With $80M Funding For Tregs Diabetes Candidate
28 Oct 2025 //
FIERCE BIOTECH
Abbvie`s Rinvoq Beats Humira In Key Arthritis Trial
22 Oct 2025 //
INDPHARMAPOST
Upadacitinib Outperforms Adalimumab In Rheumatoid Arthritis Study
20 Oct 2025 //
PR NEWSWIRE
AbbVie Completes Acquisition of Gilgamesh Pharma` Bretisilocin
17 Oct 2025 //
PR NEWSWIRE
Enveric Bio Hires IP Firm to Defend Patent Linked to AbbVie Deal
15 Oct 2025 //
PHARMIWEB
FDA Approves Abbvie`s Upadacitinib For Inflammatory Bowel Disease
14 Oct 2025 //
PRESS RELEASE
Abbvie Presents ADC Data For Hard-To-Treat Cancers At ESMO 2025
14 Oct 2025 //
INDPHARMAPOST
Abbvie Showcases Solid Tumor Targeted Therapy Leadership At ESMO
13 Oct 2025 //
PR NEWSWIRE
AbbVie Reports Positive Ph2 ELATE Data for Botox in Tremor
06 Oct 2025 //
PRESS RELEASE
Calico Gets FDA Fast Track for ADPKD Investigational Treatment
02 Oct 2025 //
PR NEWSWIRE
Abbvie Commences $70m Biologics Manufacturing Site Construction
01 Oct 2025 //
FIERCE PHARMA
Bms, Takeda Join Peers In Push To Improve AI By Pooling Data
01 Oct 2025 //
FIERCE BIOTECH
Abbvie Enters Psychedelics Space, Signaling New Era
22 Sep 2025 //
BIOSPACE
AbbVie-Partnered Protein Degrader Specialist Plexium raises $60M
29 Aug 2025 //
FIERCE BIOTECH
AbbVie Halts IL-1 Asset Development for Ulcerative Colitis
31 Jul 2025 //
FIERCE BIOTECH
AbbVie`s Phase 3 Trial of Upadacitinib for Alopecia Areata
30 Jul 2025 //
PRESS RELEASE
Abbvie Submitted sNDA for Venetoclax in Untreated CLL
30 Jul 2025 //
PRESS RELEASE
Botox Cosmetic Picks Entrepreneurs for Confidence Project
22 Jul 2025 //
PR NEWSWIRE
AbbVie & IGI Ink Global Deal For ISB 2001 Licensing Rights
12 Jul 2025 //
PRESS RELEASE
AbbVie to buy Capstan for up to $2.1B in Immunology Push
01 Jul 2025 //
PRESS RELEASE
Turnstone, once allied with AbbVie, accepts $8M Xoma buyout
30 Jun 2025 //
FIERCE BIOTECH
AbbVie Showcases Data on Solid Tumors and Blood Cancers at ASCO
27 May 2025 //
PRESS RELEASE
AbbVie Dives Further Into siRNA With $335M Upfront in ADARx Deal
15 May 2025 //
PRESS RELEASE
US FDA approves AbbVie`s drug for a type of lung cancer
15 May 2025 //
PRESS RELEASE
Techbio Pioneer Etcembly Signs Deal With DJS Antibodies
12 May 2025 //
BUSINESSWIRE
Botox Backs Entrepreneurs via Confidence Project
01 May 2025 //
PR NEWSWIRE
